Ghodoussipour Saum, Daneshmand Siamak
USC/Norris Comprehensive Cancer Center, Institute of Urology, Los Angeles, CA 90089, USA.
Transl Androl Urol. 2020 Jan;9(Suppl 1):S74-S82. doi: 10.21037/tau.2019.09.43.
The surgical management of disseminated disease has long been an essential component in the management of patients with testis cancer. While the indications for surgery have been narrowed since the advent of cisplatin based chemotherapy, resection remains essential to provide long-term survival. The indications for surgery vary by histology and rely on adequate preoperative imaging to evaluate for residual disease. Surgery for postchemotherapy testis cancer is challenging and requires that surgeons be prepared for extraretroperitoneal resections and adjunctive procedures as necessary. Herein, we review the imaging options that are essential for surgical planning and the various surgical techniques that are often necessary in this challenging situation.
播散性疾病的外科治疗长期以来一直是睾丸癌患者治疗的重要组成部分。自从基于顺铂的化疗出现以来，手术指征虽已有所缩小，但切除对于实现长期生存仍然至关重要。手术指征因组织学类型而异，并且依赖于充分的术前影像学检查以评估残留疾病。化疗后睾丸癌的手术具有挑战性，要求外科医生做好必要时进行腹膜后切除术及辅助手术的准备。在此，我们回顾了手术规划所必需的影像学检查选项以及在这种具有挑战性的情况下经常需要采用的各种手术技术。
